Fig. 4From: Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysisRank of the cumulative probabilities for primary outcomes. Note: a: the clinical effectiveness rate; b: the incidence of ADRsBack to article page